Alyeska Investment Group
AKLI

Alyeska Investment Group’s Akili Inc AKLI Stock Holding History

Alyeska Investment Group’s Portfolio AKLI Stock Details AKLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-672,500
Closed -$328K – 652
2023
Q4 		$328K Buy
672,500
+400,110
+147% +$185K ﹤0.01% 456
2023
Q3 		$150K Sell
272,390
-400,110
-59% -$397K ﹤0.01% 465
2023
Q2 		$746K Hold
672,500
– – 0.01% 475
2023
Q1 		$1.08M Sell
672,500
-99,890
-13% -$156K 0.01% 387
2022
Q4 		$865K Buy
772,390
+500,000
+184% +$880K 0.01% 355
2022
Q3 		$616K Sell
272,390
-330,564
-55% -$2.37M 0.01% 353
2022
Q2 		$5.96M Hold
602,954
– – 0.07% 264
2022
Q1 		$5.96M Buy
602,954
+125,805
+26% +$1.24M 0.07% 267
2021
Q4 		$4.74M Hold
477,149
– – 0.05% 297
2021
Q3 		$4.75M Sell
477,149
-22,851
-5% -$226K 0.06% 343
2021
Q2 		$5.05M Buy
+500,000
New +$5.05M 0.06% 338

Other funds holding AKLI

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $244M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's AKLI Position: Q1 2024 in Review

Alyeska Investment Group sold out of Akili Inc (AKLI) in Q1 2024, closing a stake of 672,500 shares — an estimated $328K sold.

Alyeska Investment Group first reported a position in AKLI in Q2 2021 and held it in 11 quarters. The position peaked at $5.96M in Q2 2022. 34 funds tracked by Wall St. Rank hold AKLI as of Q1 2024.

  • Alyeska Investment Group reported no remaining Akili Inc position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 672,500 Akili Inc shares in Q1 2024, an estimated $328K.
  • Alyeska Investment Group first reported a position in Akili Inc in Q2 2021 and held it in 11 quarters.
  • Alyeska Investment Group's Akili Inc position peaked at $5.96M in Q2 2022.
  • 34 funds tracked by Wall St. Rank held Akili Inc as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.